Institute of Pharmacology and Structural Biology-France
Author Profile
Early Academic Pursuits
Dr. Priyanka Sharma's academic journey commenced with a Bachelor's Degree in Biological Sciences from Kirori Mal College, Delhi University, India. She further pursued a Master of Science in Biomedical Science at ACBR, Delhi University, before embarking on her Ph.D. journey at the Institute of Genomics and Integrative Biology (IGIB), Delhi, India. Priyanka's dedication to biomedical research laid a strong foundation for her subsequent endeavors in epigenetics and cancer biology.
Professional Endeavors
Dr. Priyanka Sharma's professional career reflects a trajectory of continuous growth and expertise in the field of epigenetic mechanisms in cancer. Following her Ph.D., she undertook a Junior Postdoctoral Fellowship at the Epigenetic Regulation unit, Institute Pasteur, Paris, France, under the supervision of Christian Muchardt. Subsequently, she transitioned to various prestigious roles, including Novartis and Marie Curie Postdoctoral Fellowships at the Centre for Genomic Regulation (CRG), Barcelona, Spain. Priyanka's journey culminated in her current position as a Junior Group Leader at the Institute of Pharmacology and Structural Biology, where she leads the Epigenetic Mechanisms in Cancer Team.
Contributions and Research Focus
Dr. Priyanka Sharma's research focuses on unraveling epigenetic mechanisms underlying cancer initiation and progression. Her interdisciplinary approach integrates genomic and structural biology techniques to decipher the role of chromatin modifications in cancer development. Priyanka's work elucidates novel therapeutic targets and biomarkers for cancer diagnosis and treatment. Her contributions significantly advance understanding in the field, paving the way for innovative strategies in precision oncology.
Accolades and Recognition
Dr. Priyanka Sharma's dedication to scientific inquiry has been recognized through numerous awards and fellowships. Notable accolades include prestigious fellowships from institutions such as Novartis, Marie Curie, and the French National Institute of Health and Medical Research (INSERM). Her research presentations have been honored with awards, underscoring the significance and impact of her work within the scientific community.
Priyanka Sharma's remarkable achievements in oncology research have earned her the prestigious Cancer Award. With a career dedicated to unraveling the complexities of cancer biology, Priyanka's contributions have significantly advanced our understanding of the disease. Her innovative research initiatives and unwavering commitment to excellence make her a deserving recipient of this esteemed recognition.
Impact and Influence
Dr. Priyanka Sharma's research has made a profound impact on cancer biology and epigenetics, contributing to the collective knowledge of oncogenesis and therapeutic interventions. By elucidating the molecular mechanisms driving cancer progression, her work informs the development of targeted therapies and personalized medicine approaches. Priyanka's leadership as a Junior Group Leader fosters collaboration and innovation, further amplifying the impact of her research on cancer research and patient care.
As a trailblazing researcher, Priyanka Sharma has made significant strides in elucidating key mechanisms underlying cancer initiation, progression, and treatment resistance. Her work not only sheds light on the molecular pathways driving malignancy but also identifies novel therapeutic targets for improved patient outcomes.
Legacy and Future Contributions
Dr. Priyanka Sharma's legacy lies in her relentless pursuit of scientific excellence and her commitment to advancing cancer research. As she continues to lead her team in investigating epigenetic mechanisms in cancer, Priyanka's future contributions hold promise for groundbreaking discoveries and transformative interventions in oncology. Through mentorship and collaboration, she aims to inspire the next generation of scientists and drive progress towards a future where cancer is conquered through precision medicine approaches.
Citations
- Citations 1160
- h-index 11
- i10-index 11
Notable Publication